(The global market for coronary stents worldwide is assessed in the MedMarket Diligence report #C245, "Worldwide Market for Drug-Eluting, Bare Metal and Other Coronary Stents, 2008-2017.")
The market for coronary stents in Asia and the Pacific region contains both China (early technology adopters) and Japan (with a longer regulatory approval cycle), which generated a combined majority of stent sales from the region. The Asia/Pacific market for coronary stents is forecasted to grow 6.7% annually over the period from 2008 to 2017.
In terms of stent type, the Asia/Pacific market is dominated by drug-eluting stents, which represent roughly 80% of the market—a much larger portion of the stent market than seen in other regions. This is due to the fact that in China, nearly 100% of coronary stents used are drug-eluting. The remaining 20% of the market represented by bare metal stents are largely in those areas outside China.
The introduction of bioabsorbable stents will increase the total market for coronary stents and reduce the dominance of "non-bioabsorbable" drug-eluting stents in the market, although (as we have implied) a share of bioabsorbable stents will be of the drug-coated variety.
Data sourced from MedMarket Diligence Report #C245 (published 2Q 2009).
Post a Comment